{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:40:51Z","timestamp":1768005651692,"version":"3.49.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,1]]},"DOI":"10.1002\/ejhf.3299","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T07:49:07Z","timestamp":1715759347000},"page":"1432-1434","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Which Patients with Non-Ischaemic Cardiomyopathy Should Receive a Defibrillator?"],"prefix":"10.1093","volume":"26","author":[{"given":"Sam","family":"Straw","sequence":"first","affiliation":[{"name":"University of Leeds , Leeds ,","place":["UK"]},{"name":"Bradford Teaching Hospitals Foundation Trust , Bradford ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Flett","sequence":"additional","affiliation":[{"name":"University of Southampton , Southampton ,","place":["UK"]},{"name":"University Hospital Southampton , Southampton ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus K.","family":"Witte","sequence":"additional","affiliation":[{"name":"University of Leeds , Leeds ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"key":"2026010913060996500_ejhf3299-bib-0001","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"2026010913060996500_ejhf3299-bib-0002","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"2026010913060996500_ejhf3299-bib-0003","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"2026010913060996500_ejhf3299-bib-0004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026010913060996500_ejhf3299-bib-0005","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/europace\/eux089","article-title":"Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: Results of the European Heart Rhythm Association survey","volume":"19","author":"Haugaa","year":"2017","journal-title":"Europace"},{"key":"2026010913060996500_ejhf3299-bib-0006","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/heartjnl-2020-317984","article-title":"Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II","volume":"107","author":"Blacher","year":"2021","journal-title":"Heart"},{"key":"2026010913060996500_ejhf3299-bib-0007","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/ejhf.3239","article-title":"New York Heart Association functional class and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: Extended follow-up of the DANISH trial","volume":"26","author":"Karacan","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026010913060996500_ejhf3299-bib-0008","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jacc.2020.05.061","article-title":"Long-term outcomes of implantable cardioverter-defibrillator therapy in\u2009the\u2009SCD-HeFT","volume":"76","author":"Poole","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026010913060996500_ejhf3299-bib-0009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609758","article-title":"Declining risk of sudden death in heart failure","volume":"377","author":"Shen","year":"2017","journal-title":"N Engl J Med"},{"key":"2026010913060996500_ejhf3299-bib-0010","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jchf.2020.06.015","article-title":"Sacubitril\/valsartan and sudden cardiac death according to implantable cardioverter-defibrillator use and heart failure cause: A PARADIGM-HF analysis","volume":"8","author":"Rohde","year":"2020","journal-title":"JACC Heart Fail"},{"key":"2026010913060996500_ejhf3299-bib-0011","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/jamacardio.2022.3736","article-title":"Effect of dapagliflozin on cause-specific mortality in patients with heart failure across the spectrum of ejection fraction: A participant-level pooled analysis of DAPA-HF and DELIVER","volume":"7","author":"Desai","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2026010913060996500_ejhf3299-bib-0012","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ejhf.2046","article-title":"Optimized implementation of cardiac resynchronization therapy: A call for action for referral and optimization of care: A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology","volume":"22","author":"Mullens","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026010913060996500_ejhf3299-bib-0013","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/CIRCULATIONAHA.120.048477","article-title":"Relationship of LVEF and myocardial scar to long-term mortality risk and mode of death in patients with nonischemic cardiomyopathy","volume":"143","author":"Klem","year":"2021","journal-title":"Circulation"},{"key":"2026010913060996500_ejhf3299-bib-0014","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"2026010913060996500_ejhf3299-bib-0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ahj.2023.09.008","article-title":"Rationale and study protocol for the BRITISH randomized trial (using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure)","volume":"266","author":"Flett","year":"2023","journal-title":"Am Heart J"},{"key":"2026010913060996500_ejhf3299-bib-0016","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ahj.2019.10.020","article-title":"Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure \u2013 DANISH-MRI","volume":"221","author":"Elming","year":"2020","journal-title":"Am Heart J"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/26\/6\/1432\/65512031\/eurjhf_26_6_1432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/26\/6\/1432\/65512031\/eurjhf_26_6_1432.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:07:16Z","timestamp":1767982036000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/26\/6\/1432\/8328739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":16,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,5,15]]},"published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.3299","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,5,15]]},"assertion":[{"value":"2024-05-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}